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SufuThe Hedgehog (Hh) family of secreted proteins regulates mammalian development and cancer formation
through Gli transcription factors, which exist in both activator and repressor forms. In vertebrates, the
primary cilia play an essential role in Hh signal transduction and are required for both the activator and
repressor activities of Gli proteins. In the current study, we demonstrate that mouse Suppressor of Fused
(Sufu) interacts with Gli proteins and inhibits Gli activator activity in the absence of cilia. Removal of Sufu in
both Smoothened (Smo) and Ift88 mutants, respectively, leads to full activation of Hh signaling, suggesting
that Smo-mediated repression of Sufu, but not the inhibitory function of Sufu, requires cilia. Finally, we show
that Sufu is important for proper activator/repressor ratio of Gli3 protein in mice, both in the presence and
absence of cilia.© 2009 Elsevier Inc. All rights reserved.IntroductionHedgehog (Hh) proteins are critical for development of diverse
animal species (Hooper and Scott, 2005). In Drosophila, Cubitus
interruptus (Ci) mediates all transcriptional responses to Hh signaling
(Methot and Basler, 2001). Hh inhibits the proteolytic processing of Ci
that turns it into a transcriptional repressor. In addition, high levels of
Hh convert Ci into a transcriptional activator. Intracellular transduc-
tion of Hh signals involves many proteins including transmembrane
proteins Patched (Ptc), and Smoothened (Smo), and cytoplasmic
regulators such as Fused kinase, kinesin-like protein Costal-2 and
Suppressor of Fused (Sufu). In vertebrates, there are three homologs of
Ci, Gli1, 2 and 3. Gli3 is efﬁciently processed into a transcriptional
repressor in vivo (Wang et al., 2000). Gli2 acts as the primary activator
in vivo, in part due to inefﬁcient processing (Pan et al., 2006). Gli1
expression is dependent on Hh signaling, hence it acts as a secondary
activator to enhance pathway activation (Bai et al., 2004).
Sufu is largely dispensable for Hh signaling in Drosophila and its
role in Hh signaling can only be fully revealed when a positive
regulator of Hh signaling (e.g. Fu) is also mutated (Preat, 1992). Byerly College of Science, The
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l rights reserved.contrast, loss of Sufu function leads to full activation of Hh signaling in
mammals (Cooper et al., 2005; Svard et al., 2006). In vertebrates, Sufu
inhibits Gli-mediated transcriptional activation in the nucleus by
recruiting a histone deacetylation complex to Gli target genes (Cheng
and Bishop, 2002; Paces-Fessy et al., 2004). Sufu also sequesters Gli in
the cytoplasm in the absence of Hh (Ding et al., 1999; Dunaeva et al.,
2003; Kogerman et al., 1999; Merchant et al., 2004; Pearse et al., 1999;
Stone et al., 1999), but the molecular mechanism underlying this
sequestration remains elusive.
Through the study of mouse mutants for intraﬂagellar transport
genes (IFT genes, including Ift88) that fail to form cilia, we have
recently discovered an essential role for cilia in Hh signal transduction
(Huangfu et al., 2003). Paradoxically, IFT mutants exhibit phenotypes
characteristic of loss of transcriptional activator function of Gli
proteins (GliA) despite the presence of full-length Gli3 proteins
(Haycraft et al., 2005; Huangfu and Anderson, 2005; Liu et al., 2005).
Ciliary localization of key Hh signaling regulators may underlie
cilia-dependent Hh signal transduction in mammals. Localization of
Ptch1 and Smo in the cilia is regulated by Hh, and appears to be
important for their function (Corbit et al., 2005; Rohatgi et al., 2007).
Sufu and Gli are also localized to the cilia, but the signiﬁcance of such
localization remains to be addressed (Haycraft et al., 2005).
In the current study, we show that Sufu physically interacts with
all three Gli proteins in both wild type and Ift88mutant cells. We also
found that Sufu is sufﬁcient and required for inhibiting Gli-mediated
transcriptional activation in Ift88 mutant cells, suggesting that Sufu
remains functional in the absence of cilia. Furthermore, double
Fig.1. Ciliadonot form in Ift88mutantMEFs. (A)GenomicPCRsusingprimers speciﬁc towild
type or Ift88mutant allele are performedonMEF cell lysates. Nowild typeproduct is detected
in the Ift88mutant cells. DNA prepared from the tail of a heterozygous Ift88mutantmouse is
used as control. (B) Western blot is performed on MEF cell lysates using an IFT88-speciﬁc
antibody. No IFT88 protein is detected in the Ift88mutant MEFs. Tubulin is used as a loading
control. (C) Acetylated α-tubulin is present in the basal body (arrowhead) and axoneme
(arrow) of the cilia in wild type cells. (D) Acetylated α-tubulin is present in punctuate
doublets (arrowheads) in Ift88mutant cells. (E, F) γ-tubulin is present in punctuate doublets
(arrowheads) in both wild type (E) and Ift88mutant (F) cells. DNA is stained blue in C–F.
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function in both Ift88 and Smo mutants. Finally, we found that the
ratio between the activator and repressor forms of Gli3 protein, asFig. 2. Sufu physically interacts with all Gli proteins in the absence of cilia. (A–C) Sufu co-imm
and Ift88mutant cells. (D) Endogenous Gli3 co-immunoprecipitates with Sufu, but not by un
assembled from one single experiment in which the same experimental procedure was appli
with 10% of protein lysate used for immunoprecipitation.well as the total level of Gli3 protein in the embryos, is drastically
affected by the loss of Sufu function, in the presence and absence of
cilia. In conclusion, our data indicate that cilia are dispensable for the
function of Sufu in regulating the activity, processing and level of Gli
proteins.
Materials and methods
Mutant mice and analysis
Ift88 (Murcia et al., 2000), Sufu (Svard et al., 2006) and Smo
(Zhang et al., 2001) mutant mice and embryos were genotyped as
described. Immunohistochemistry is performed as described (Hoover
et al., 2008).
Primary cell culture and immunocytochemistry
Mouse embryonic ﬁbroblasts were generated from individual E9.5
embryos as described (Hoover et al., 2008; Svard et al., 2006).
Speciﬁcally, cells from individual E9.5 embryos were dissociated by
passage through Gauge 20 needles, and plated in DMEM/F12
supplemented with 15% fetal bovine serum (FBS), non-essential
amino acid, sodium pyruvate, Glutamax and antibiotics, at 37 °C and
5% CO2. In order to conﬁrm the genotypes of the wild type and Ift88
mutant cells, cells are allowed to grow conﬂuent in a 60 mm dish and
lysed, followed by polymerase chain reaction (PCR) and immunoblot
assays.
To visualize primary cilia, cells growing on gelatin-coated glass
coverslips for 48 h in medium containing 0.5% FBS are labeled with
antibodies against acetylated tubulin (Sigma, T7451) or γ-tubulin
(Sigma, T5326), and visualized under a Nikon E600 microscope.
Cell transfection and reporter assays
Transient cell transfection was performed using Lipofectamine
2000 (Invitrogen). An 8×GliBS-ﬁreﬂy luciferase reporter was used for
quantitation of GliA activity (Sasaki et al., 1997), Human Gli1, Gli3 and
mouseGli2, Sufuwere cloned intomammalian expression vectorswith
Myc (pCS2+), FLAG (pFLAG-CMV2, Sigma) or GFP (pEGFPC1, Invitro-
gen) tags. Plasmids expressing shRNAs against Sufu were obtained
from Dr. Taipale and were used as described (Varjosalo et al., 2006).
pTK-RL (Renilla luciferase) was used as transfection control. Luciferase
activity was detected using a Dual-luciferase reporter assay system
(Promega), in a Modulus luminometer (Turner Biosys). Data analysesunoprecipitates with Gli1 (A), Gli2 (B) and Gli3 (C) when over-expressed in wild type
related antibodies (anti-Myc) in wild type and Ift88mutant cells. Panels shown in D are
ed to both experimental and control samples. For each panel, the input lanes are loaded
454 J. Jia et al. / Developmental Biology 330 (2009) 452–460including the student t-testswere performedusingMicrosoft Excel. All
assays were done in triplicates and repeated at least three times.
Co-immunoprecipitation and Western blotting
Co-immunoprecipitation between over-expressed proteins were
performed using a FLAG Tagged protein Immunoprecipitation kit
(Sigma). Endogenous Sufu was precipitated with a goat polyclonal
antibody (M-15, Santa Cruz Biotech) immobilized on protein A-
Agarose beads (Santa Cruz Biotech). Proteins are separated on SDS-
PAGE for immunoblots with standard procedures. Quantitation of the
immunoblots was performed using NIH ImageJ.
A rabbit polyclonal antibody against mouse IFT88 was generated
against a synthesized peptide at the N-terminus of the protein as
described (Taulman et al., 2001), and its speciﬁcity was conﬁrmed by
immunoﬂuorescence and immunoblot assays with whole cell lysates
of wild type and Ift88 mutant embryos. Gli3 was detected with two
rabbit polyclonal antibodies (Chen et al., 2004; Wang et al., 2000). A
rabbit polyclonal antibody (H-300, Santa Cruz Biotech) was used to
detect endogenous Sufu in immunoblots to avoid cross-reaction with
goat IgG used for immunoprecipitation. Actin (anti-Actin, Santa Cruz
Biotech) and tubulin (anti-α/β-Tubulin, Cell Signaling) serve as
loading controls.
Results and discussion
Cilia are absent on Ift88 mutant cells
In order to unambiguously address whether Sufu requires cilia to
inhibit Gli activity and Hh signaling, it is critical to establish a tissue
culture system in which cilia formation is completely disrupted. An
apparent null allele for mouse Ift88, Ift88Δ2–3βGal (originally named
Tg737Δ2–3βGal), generated through the replacement of the ﬁrst two
coding exons with a lacZ-expression cassette, produces severely
truncated Ift88 mRNA and no IFT88 protein (Murcia et al., 2000;
Taulman et al., 2001). As a result, cilia formation is completely
disrupted in Ift88Δ2–3βGal homozygous mutant embryos (Murcia et al.,
2000; and our unpublished data). We established primary embryonic
ﬁbroblast (MEF) culture from these mutant embryos as well as their
wild type littermates as control. To test whether we have established a
pure culture of Ift88Δ2–3βGal homozygous mutants, we performed
genomic PCR that distinguishes the Ift88Δ2–3βGal allele from the wild
type allele. No wild type PCR product was detected in the mutant cell
lysate after 55 cycles of ampliﬁcation, indicating no contamination
fromwild type or heterozygous cells (Fig. 1A). We further tested these
cells in an immunoblot assay with a mouse IFT88 speciﬁc antibody
and conﬁrmed the absence of IFT88 protein (Fig. 1B). Finally, we
examined whether cilia formation is completely disrupted in these
cells via immunocytochemistry. Using an antibody against acetylated
α-tubulin, we labeled the axonemes and the basal bodies of the
primary cilia (Fig. 1C, 308/356=86% ciliated). In Ift88Δ2–3βGal
homozygous mutant cells, no axonemal staining was detected (Fig.
1D, n=388). Instead, we found punctuate doublet staining in many
mutant cells characteristic of the basal bodies or centrosomes (Fig.
1D). We conﬁrmed the presence of the basal bodies or centrosomes inFig. 3. Sufu inhibits Gli activities in the absence of cilia. Wild type and Ift88 mutant
MEFs are co-transfected with a Gli-responsive luciferase reporter and various effectors.
Activities of the ﬁreﬂy luciferase are plotted to reﬂect the relative expression level of the
reporter. (A) Sufu inhibits Gli1-mediated activation of the reporter in wild type and
Ift88 mutant cells. (B) Sufu inhibits Gli2-mediated activation of the reporter in wild
type and Ift88mutant cells. (C) Reducing the level of Sufu protein by RNA interference
activates a Gli-responsive reporter expression in both wild type and Ift88mutant cells.
Immunoblots below each chart shows the relevant proteins present in the same volume
of lysate used for luciferase activity measurement. In C, the relative amount of Sufu
protein is calculated and shown below the immunoblots. The amount in cells treated
with scrambled shRNA is arbitrarily set to 1.the Ift88Δ2–3βGal mutant cells with the basal body/centrosome marker
γ-tubulin (Figs. 1E, F). In summary, we had established an in vitro
tissue culture system to speciﬁcally address the requirement for
primary cilia. For the rest of this report, we will refer to homozygous
Ift88Δ2–3βGal mutant (cells and embryos) as Ift88 mutant.
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We ﬁrst examined whether Sufu interacts with Gli proteins in the
absence of cilia through co-immunoprecipitation analyses between
Sufu and all three Gli proteins. As previously reported (Ding et al.,
1999; Dunaeva et al., 2003; Kogerman et al., 1999; Pearse et al., 1999;
Stone et al., 1999), over-expressed Gli1, Gli2 and Gli3 co-immunopre-
cipitate with Sufu in wild type mouse embryonic ﬁbroblasts (MEFs;
Figs. 2A–C). Interestingly, Sufu co-immunoprecipitates with all three
Gli proteins in Ift88 mutant MEFs, indicating that the physical
interactions between Sufu and Gli proteins are not dependent on
cilia (Figs. 2A–C).
We next examined whether endogenous Sufu interacts with Gli
proteins in the absence of cilia, using antibodies capable of detecting
endogenous Sufu and Gli3 in immunoblots. We found that endogenous
Sufu and Gli3 co-immunoprecipitate in both wild type and Ift88mutant
cells, indicating that their interaction does not depend on cilia (Fig. 2D).
Sufu inhibits Gli-activated reporter expression in the absence of cilia
We next addressed whether Sufu inhibits GliA activity in the
absence of cilia using a Gli-responsive reporter (Sasaki et al., 1999).
Consistent with a previous report, over-expression of Gli1 signiﬁcantly
activates reporter expression in both wild type and Ift88 mutant cells
(Fig. 3A, pb0.01) (Haycraft et al., 2005). Interestingly, when we co-
transfected the cells with Gli1 and Sufu, the expression of the reporter
is decreased in both wild type and Ift88mutant cells compared to the
cells transfected with Gli1 alone, suggesting that Sufu inhibits GliA
function in the absence of cilia (Fig. 3A, pb0.01).Fig. 4. Sufu is epistatic to Ift88. (A–D) lateral views of E9.5 mouse embryos. Arrowheads in B
no neural ridge elevation in the brains of the Sufu (C) and Sufu/Ift88 double (D)mutant embr
hybridization. Ptch1 expression is reduced in an Ift88 mutant embryo (F), but upregulated in
whole embryos detected by wholemount RNA in situ hybridization. Gli1 expression is reduc
(L) mutant embryos.We next examined whether Gli2, the primary activator of the Hh
signaling, is subject to inhibitory control by Sufu in the absence of cilia.
We found that Gli2 activates reporter expression, and that this
activation is inhibited by Sufu, in both wild type and Ift88mutant cells
(Fig. 3B, pb0.01).
Our result is different from a previous report that over-
expression of Gli1, but not Gli2, activates Ptch1 expression in the
absence of cilia (Haycraft et al., 2005). The difference in the levels
of Gli2 expression, which was not shown in the previous report, is
one possible explanation. Alternatively, our use of a reporter gene
solely responsive to GliA activation could underlie the differential
outcome since the regulation of endogenous Ptch1 expression may
be more complex. Finally, we normalized our reporter expression
against a co-transfected Renilla-luciferase control in order to
eliminate the impact of differing transfection efﬁciency. In contrast,
in the previous report, Ptch1 expression was normalized against
actin, which is expressed in both transfected and non-transfected
cells.
Reducing Sufu protein level activates Hh signaling in the absence of cilia
If the inhibitory function of Sufu on Gli activity is dependent on
cilia, reducing Sufu in Ift88mutant cells should not affect Hh signaling.
We hence reduced the level of Sufu inwild type and Ift88mutant cells
by RNA interference (RNAi). As reported previously (Varjosalo et al.,
2006), a moderate reduction of Sufu protein (by 35%–60%) signiﬁ-
cantly activates the Gli-responsive reporter gene expression in wild
type cells (Fig. 3C, pb0.01). We found similar activation of the
reporter gene expression in Ift88 mutant cells, indicating that Sufupoint to elevated neural ridges in the brain of an Ift88mutant embryo. Note that there is
yos. (E–H) Ptch1 expression in E9.5 whole embryos detected bywholemount RNA in situ
the Sufu (G) and Sufu/Ift88 double (H) mutant embryos. (I–L) Gli1 expression in E9.5
ed in an Ift88mutant embryo (J), but upregulated in the Sufu (K) and Sufu/Ift88 double
456 J. Jia et al. / Developmental Biology 330 (2009) 452–460retains its inhibitory function on GliA in the absence of cilia (Fig. 3C,
pb0.01).
The relationship between Sufu and cilia was examined in a recent
study with MEFs derived from mouse embryos carrying a point
mutation in Ift172, encoding another IFT complex component, or an
in-frame deletion in Dnchc2, encoding a subunit of the retrograde IFT
motor (Ocbina and Anderson, 2008). In contrast to our results, it was
reported that mutations in these two genes completely abolished the
ability of the cells to activate Hh signaling in response to the reduction
of Sufu. This is surprising especially because ciliogenesis is not
completely blocked and Hh signaling is less severely disrupted in
Dnchc2 mutant embryos compared to the Ift88 mutant cells used in
our study (Huangfu and Anderson, 2005). It is not yet clear what
underlies the difference between the reported result and ours
regarding the relationship between Sufu and cilia. However, as
detailed below, our conclusion that Sufu remains functional in the
absence of cilia is well supported by in vivo epistatic analysis. It is
critical to determine whether these two genes (Ift172 and Dnchc2) are
fully epistatic to Sufu, as suggested by their in vitro results, in a more
stringent in vivo double mutant analysis.Fig. 5. Sufu regulates spinal cord patterning in the absence of cilia. (A) Foxa2 labels the ﬂoor
Pax6 is present in the neural progenitor cells of the dorsal two-thirds of the spinal cord. (D
spinal cord in Ift88mutants. (G) Foxa2 and (H) Nkx2.2 are present throughout the spinal cord
Nkx2.2 are present throughout the spinal cord of Sufu/Ift88 double mutants. (L) Pax6 is abse
transverse sections of E9.5 embryos. Dashed lines outline the spinal cords.Sufu inhibits Hh signaling in developing embryos in the absence of cilia
The ability of Sufu to inhibit GliA activity in cultured cells despite
the complete loss of cilia suggests that the inhibitory function of Sufu
may be responsible for the lack of GliA activity in Ift88 mutant
embryos. We tested this hypothesis by examining Hh signaling in
Sufu/Ift88 double homozygous mutants.
At E9.5, the homozygous Sufu and Ift88 mutant embryos are
morphologically distinct (Cooper et al., 2005; Murcia et al., 2000;
Svard et al., 2006). In Ift88 mutants, the neural tube closure defects
(NTD) are restricted to the midbrain and posterior forebrain (Figs.
4A, B). Moreover, in the brain region with NTD, the neural ridges are
elevated, suggesting that the initiation of neurulation is not
disrupted. In contrast, Sufu mutants exhibit extensive NTD including
the entire brain and part of the spinal cord with no neural ridge
elevation (Fig. 4C). Sufu/Ift88 double mutant embryos are morpho-
logically indistinguishable from Sufu single mutants, suggesting Sufu
is epistatic to Ift88 (Fig. 4D).
To address whether themorphological similarity between Sufu and
Sufu/Ift88 double mutants is associated with similar Hh signalingplate in wild type spinal cord. (B) Nkx2.2 labels the precursors for V3 interneurons. (C)
) Foxa2 and (E) Nkx2.2 are absent in Ift88 mutants. (F) Pax6 is present throughout the
of the Sufumutants. (I) Pax6 is absent in the Sufumutant spinal cord. (J) Foxa2 and (K)
nt in the Sufu/Ift88 double mutant spinal cord. Shown are immunoﬂuorescent images of
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in these embryos. Both genes are expressed in tissues adjacent to the
source of Hh ligands, such as the ventral neural tube and somites (Figs.
4E, I). In Ift88mutants, expression of both genes is reduced, suggesting
reduced Hh signaling and GliA function (Figs. 4F, J). In Sufu mutants,
Gli1 and Ptch1 are highly expressed in broad regions of the embryo,
indicating ectopic activation of the Hh signaling pathway (Figs. 4G, K).
Sufu/Ift88 double mutants exhibit the same broad expression of Gli1
and Ptch1 as Sufumutants, indicating that Hh signaling remains under
the negative regulation of Sufu in the absence of cilia (Figs. 4H, L).
Sufu regulates ventral spinal cord patterning in the absence of cilia
Hh signaling plays essential roles in establishing the dorsal–ventral
patterning in the spinal cord (Dessaud et al., 2008). Therefore, by
comparing the spinal cord patterning in Sufu/Ift88 double mutant
embryos with those in Sufu and Ift88 single mutants, we can
determine the genetic interaction between the two genes in Hh
pathway regulation. At E9.5, the ﬂoorplate marker Foxa2 and a marker
for V3 interneuron precursors Nkx2.2 are co-expressed in the ventral-
most region of the spinal cord (Figs. 5A, B). Pax6 is strongly expressed
in the progenitor cells for the dorsal and lateral interneurons, as well
as motor neurons (Fig. 5C). In Ift88 mutant spinal cord, Foxa2 and
Nkx2.2-expressing cells are absent, whereas Pax6 is expressedFig. 6. Sufu regulates spinal cord patterning downstream of Smo. (A) Nkx2.2 labels the precu
two-thirds of the spinal cord. (C) Pax7 is present in the dorsal progenitor cells of the wild ty
spinal cord in Smomutants. (F) Pax7 is present throughout the spinal cord in Smomutants. (G
Sufumutant spinal cord. (I) Pax7 is absent in the Sufumutant spinal cord. (J) Nkx2.2 is presen
Smo double mutant spinal cord. (L) Pax7 is absent in the Sufu/Smo double mutant spinal cord
lines outline the spinal cord.throughout the DV axis (Figs. 5D–F). By contrast, the Sufu mutant
spinal cords are severely ventralized, with Foxa2 and Nkx2.2-
expression expanded into the dorsal spinal cord (Figs. 5G,H). Pax6,
on the other hand, is not expressed (Fig. 5I). Sufu/Ift88 double
mutants exhibit spinal cord ventralization indistinguishable from Sufu
mutants, suggesting activation of Hh signaling in all spinal cord cells
(Figs. 5J–L).
The full activation of Hh signaling in Sufu/Ift88 double mutants
strongly indicates that Sufu retains its inhibitory function in the
absence of cilia and is likely responsible for the lack of GliA activity in
Ift88mutants. Therefore, we concluded that the inhibitory function of
Sufu on GliA activity and Hh signaling does not rely on cilia, despite
their co-localization to the tip of primary cilia in wild type cells
(Haycraft et al., 2005).
Smo activates Hh signaling by antagonizing the inhibitory function
of Sufu
Smo is translocated to the primary cilia in the presence of Hh
ligand, and its ciliary localization is essential for Hh pathway
activation (Corbit et al., 2005). We hypothesize that the ciliary
translocation of Smo allows it to antagonize the function of Sufu,
hence activating GliA function. This hypothesis predicts that the
function of Smo can only be revealed in the presence of both cilia andrsors for V3 interneurons. (B) Pax6 is present in the neural progenitor cells of the dorsal
pe spinal cord. (D) Nkx2.2 is absent in Smomutants. (E) Pax6 is present throughout the
) Nkx2.2 is present throughout the spinal cord of Sufumutant. (H) Pax6 is absent in the
t throughout the spinal cord of Sufu/Smo double mutant. (K) Pax6 is absent in the Sufu/
s. Shown are immunoﬂuorescent images of transverse sections of E9.5 embryos. Dashed
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signaling in the absence of cilia (Huangfu and Anderson, 2005). We
sought to address the relationship between Smo and Sufu by
characterizing the spinal cord patterning in Sufu/Smo doublemutants.
In order to analyze the DV patterning of the spinal cord, we
examined three genes that are expressed in neural progenitor cells at
different positions along the DV axis of E9.5 spinal cord. Nkx2.2 is
expressed in the precursors of V3 interneurons, which is the ventral-
most neuronal cell type (Fig. 6A). Pax6 is expressed in dorsal two-
thirds of the spinal cord (Fig. 6B). Pax7 labels the dorsal-most region
of the spinal cord (Fig. 6C). In the Smomutant spinal cord, a lack of Hh
signaling activity leads to the loss of Nkx2.2 expression (Fig. 6D), as
well as the ventral expansion of Pax6 and Pax7 expression (Figs. 6E, F).
In Sufu mutants, Nkx2.2 is expressed throughout the DV axis of the
spinal cord (Fig. 6G), whereas the expression of Pax6 and Pax7 is
absent (Figs. 6H, I). The Sufu/Smo double mutant spinal cords are
indistinguishable from those in Sufu mutants, with widespread
Nkx2.2 expression (Fig. 6J) at the expense of Pax6 and Pax7 expression
(Figs. 6K, L). The identical phenotype between Sufu mutants and
Sufu/Smo double mutants indicates that loss of Smo has no impact on
Hh signaling and embryonic patterning in the absence of Sufu,
suggesting that Smo activates GliA activity by antagonizing the
inhibitory function of Sufu.Fig. 7. Sufu regulates the ratio between the activator and repressor forms of Gli3 protein inde
type and different combinations of Sufu and Ift88mutants. Each lane was loaded with protein
(Gli3-190) and processed product (Gli3-83) inwild type E12.5 limb bud, and MEFs derived fr
in both A and B. (C) Graphical representation of the Gli3-190 versus Gli3-83 ratio in E9.5 wild
of the relative level of total Gli3 protein (Gli3-190 and Gli3-83). The relative level of Gli3 pro
due to saturation of band density in A and B. Graphics in C and D summarize data from atIt is unclear how Smo antagonizes Sufu function molecularly. It
could directly interact with Sufu. Alternatively, it might modify Gli
proteins such that they are no longer subject to Sufu inhibition. In
either scenario, genetic data suggest that this function of Smo requires
cilia (Huangfu and Anderson, 2005). In the absence of cilia, Gli is
under constitutive inhibition of Sufu, leading to the loss of GliA
activity. At least in the case of Gli3, this occurs despite an increase in
the level of full-length Gli3 protein as the result of reduced proteolytic
processing.
Loss of Sufu alters the ratio between the activator and repressor forms of
Gli3 protein
Gli3 is proteolytically processed from a 190-kD precursor (Gli3-
190) into an 83-kD transcriptional repressor (Gli3-83) in vivo and this
processing is regulated by Hh signaling (Wang et al., 2000; Fig. 7). We
sought to address whether the Gli3-190/Gli3-83 ratio is regulated by
Sufu andwhether this regulation is affected by the loss of cilia. For this
purpose, we directly examined Gli3 protein by immunoblots in Sufu
and Sufu/Ift88 double mutants.
We ﬁrst examined Gli3 protein in E9.5 whole embryo extracts. In
wild type embryos, there is more Gli3-83 compared to Gli3-190, due
to efﬁcient proteolytic processing (Figs. 7A, C). We found that in bothpendent of cilia. (A) Immunoblot showing the level of Gli3-190 and Gli3-83 in E9.5 wild
extracted from a single embryo. (B) Immunoblot showing the levels of full-length Gli3
om E9.5 wild type, Sufu and Ptch1mutant embryos. Tubulin was used as loading control
type and different combinations of Sufu and Ift88mutants. (D) Graphical representation
tein in wild type was set to one. Note that the ratios in C and D may be under-estimated
least 3 embryos of each genotype.
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and C). The Gli3-190/Gli3-83 ratio appears to be much higher in Sufu
mutants compared to that in Ift88 mutants (Figs. 7A and C). The ratio
between the two forms of Gli3 in Sufu−/−;Ift88−/− double mutants is
indistinguishable from that in Sufu mutants, suggesting that Sufu
regulates the ratio between these two forms of Gli3 protein in the
absence of cilia (Figs. 7A, C). In conclusion, our results indicate that
Sufu plays essential roles in regulating the ratio between Gli3-190
and Gli3-83, likely through regulating the proteolytic processing of
Gli3. An alternative explanation is that in the absence of Sufu, Gli3-83
is highly unstable, leading to the change in the Gli3-190/Gli3-83 ratio.
We next examined Gli3 protein in MEFs derived from E9.5 mouse
embryos. Similar to what we found in the whole embryo lysates, a
signiﬁcant amount of Gli3 protein is processed into Gli3-83 in wild
typeMEFs (Fig. 7B). In contrast, Gli3-83 is barely detectable in Sufu−/−
MEFs, drastically increasing the Gli3-190/Gli3-83 ratio (Fig. 7B and
data not shown).
Interestingly, there is a drastic decrease in the total level of Gli3
protein in both Sufu and Sufu/Ift88 double homozygous mutant
embryos, as well as in cultured Sufu mutant cells (Figs. 7A, B and D).
The reduction of Gli3 protein in Sufumutant embryosmaypartly result
from the decrease in Gli3 transcription due to broad activation of Hh
signaling (Svard et al., 2006). Additionally, Sufu may play important
roles in the translation or degradation of Gli3 protein. Consistent with
this additional role for Sufu, loss of Sufu in Drosophila leads to a drastic
reduction in the level of Ci protein without affecting its transcription
(Ohlmeyer and Kalderon, 1998). We also found that the level of Gli3
protein is largely normal in Ptch1 mutants, which exhibit similar
activation of the Hh pathway to Sufu mutants, suggesting that the
drastic decrease in Gli3 protein level in Sufu mutants is not solely the
result of Hh pathway activation (Goodrich et al., 1997). Revealing the
roles of Sufu in Gli3 post-transcriptional regulation will need the
uncoupling of Gli3 transcription and Hh pathway activation. It is also
interesting to investigate the roles for Sufu in the regulation of
endogenous Gli1 and Gli2 when the antibodies are available.
In conclusion, we have provided evidence supporting cilia-
independent roles for Sufu in regulating the activator activities of Gli
proteins, as well as post-transcriptional regulation of Gli3. Molecu-
larly, Sufumay interact with Gli prior to cilia entrance. Alternatively, as
Sufu antagonizes Gli activity in the nucleus (Cheng and Bishop, 2002;
Paces-Fessy et al., 2004), our data may be an indication that cilia
localization of Sufu is not a prerequisite for its nuclear function. In
either case, our data strongly suggest that the inhibitory function of
Sufu on GliA and Hh signaling does not rely on cilia. Nevertheless, our
current work, combined with previous studies (Corbit et al., 2005;
Huangfu and Anderson, 2005), indicates that inactivation of Sufu by a
Smo-mediatedmechanism is key to the activation of GliA, and is likely
dependent on cilia. Our current work provides a parsimonious
explanation for the roles of Smo, Sufu and cilia in Gli activation, as
well as a framework for further investigation of the molecular
mechanisms underlying the cilia-dependent Hh signaling in
vertebrates.
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